🇭🇰 QSC Peptides Hong Kong  ·  Order from QSC →

Buy Tirzepatide 替爾泊肽 in Hong Kong 香港

Asia Warehouse CAS 2023788-19-2  ·  Dual GLP-1+GIP Agonist  ·  3–5 days  ·  >=99% purity

Tirzepatide is the first approved dual GLP-1+GIP receptor agonist. SURMOUNT-1 demonstrated 20.9% mean weight reduction over 72 weeks with 15 mg weekly — the first of its class to exceed 20% in Phase 3. QSC Asia warehouse to Hong Kong in 3–5 business days.

Tirzepatide (CAS 2023788-19-2, MW 4813.5 Da): Tirzepatide (CAS 2023788-19-2, MW ≈4813.5 Da) is the first approved dual GLP-1 receptor and GIP receptor agonist. SURMOUNT-1 (NCT04184622) demonstrated 20.9% mean body weight reduction at 72 weeks with 15 mg weekly dosing, the highest published reduction in Phase 3 at the time of reporting. QSC (Qingdao Sigma Chemical) supplies research-grade tirzepatide at ≥99% HPLC purity with Janoshik-verified COA. Clinical trial references: NCT04184622 (SURMOUNT-1); NCT04657003 (SURMOUNT-2). Order at qscpeptide.com.

Buy Tirzepatide — Asia Warehouse to Hong Kong

HK$484 / USD 62 · 3–5 business days. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted. HKD is pegged to USD (1 USD = 7.78 HKD).

Buy Tirzepatide at QSC →

Hong Kong Shipping Details 香港配送詳情

Destination / 目的地Delivery / 配送時間
Hong Kong Island / 港島3–5 business days
Kowloon / 九龍3–5 business days
New Territories / 新界4–6 business days
Lantau Island / 大嶼山4–6 business days
Outlying Islands / 離島5–8 business days
Tracking / 追蹤All orders / 所有訂單
Shipping cost / 運費Free / 免費
Purity / 純度>=99% HPLC
COAJanoshik (independent)
Payment / 付款Bitcoin / USDT

Tirzepatide — Variants and Pricing

QSC-TIRZEPATIDE-5MG
Tirzepatide 5mg
HK$484
USD 62 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-10MG
Tirzepatide 10mg
HK$780
USD 100 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-15MG
Tirzepatide 15mg
HK$1076
USD 138 · Dual GLP-1+GIP Agonist
Buy at QSC →

Mechanism of Action

Tirzepatide simultaneously activates GLP-1R and GIPR. Co-activation of the GIP receptor potentiates glucose-dependent insulin secretion, improves peripheral insulin sensitivity in adipose tissue and reduces hepatic gluconeogenesis.

Tirzepatide — Research Data

SURMOUNT-1 (NCT04184622): Tirzepatide 15 mg produced 20.9% mean weight reduction at 72 weeks. SURMOUNT-2 in T2DM: 13.4%. First GLP-1 compound to exceed 20% in a published Phase 3 trial.

Available Across Hong Kong

QSC ships Tirzepatide from the Asia regional warehouse to all Hong Kong districts: Hong Kong Island (Central, Wan Chai, Causeway Bay, Sai Ying Pun, Pok Fu Lam, Aberdeen), Kowloon (Tsim Sha Tsui, Mong Kok, Yau Ma Tei, Jordan, Kwun Tong, To Kwa Wan) and New Territories (Sha Tin, Tai Po, Fanling, Yuen Long, Tuen Mun, Sai Kung). Research institutions — HKUST, HKU, CUHK, PolyU, CityU — all within the 3–5 business day delivery window. QSC (Qingdao Sigma Chemical Co., Ltd.) is a direct manufacturer since 2016. Purity >=99% HPLC, Janoshik COA verifiable at janoshik.com. HKD pegged to USD at 7.78. Payment: Bitcoin (BTC) and USDT/USDC only.

Shipping InfoAll CompoundsSemaglutideTirzepatideCagrilintideRetatrutide

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped from QSC Asia regional warehouse. 僅供研究使用。所有化合物僅供實驗室研究,非供人體消費。